Multiple efforts are underway to increase the inclusion of racial minority participants in genomic research and new forms of individualized medicine. These efforts should include studies that characterize how individuals from minority communities experience genomic medicine in diverse health-care settings and how they integrate genetic knowledge into their understandings of health-care needs.
As part of a large, multisite genomic sequencing study, we surveyed individuals to assess their decision to pursue genomic risk evaluation. Participants included Latino patients recruited at Mountain Park Health Center, a Federally Qualified Health Center in Phoenix, Arizona, and non-Latino patients recruited at a large academic medical center (Mayo Clinic in Rochester, MN). Both groups agreed to receive individualized genomic risk assessments.
Comparisons between cohorts showed that Latino respondents had lower levels of decisional conflict about pursuing genomic screening but generally scored lower on genetic knowledge. Latino respondents were also more likely to have concerns about the misuse of genomic information, despite both groups having similar views about the value of genomic risk evaluation.
Our results highlight the importance of evaluating sociocultural factors that influence minority patient engagement with genomic medicine in diverse health-care settings.
Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Survey data may be made available on a case by case basis by contacting the principal investigator of the study.
Sankar, P. et al. Genetic research and health disparities. JAMA. 291, 2985–2989 (2004).
Popejoy, A. B. & Fullerton, S. M. Genomics is failing on diversity. Nature. 538, 161–164 (2016).
Hinchcliff, E. M., Bednar, E. M., Lu, K. H. & Rauh-Hain, J. A. Disparities in gynecologic cancer genetics evaluation. Gynecol. Oncol. 153, 184–191 (2019).
Manrriquez, E., Chapman, J. S., Mak, J., Blanco, A. M. & Chen, L. M. Disparities in genetics assessment for women with ovarian cancer: can we do better? Gynecol. Oncol. 149, 84–88 (2018).
Cruz-Correa, M. et al. Clinical cancer genetics disparities among Latinos. J. Genet. Couns. 26, 379–386 (2017).
Nikolaidis, C. et al. Disparities in genetic services utilization in a random sample of young breast cancer survivors. Genet. Med. 21, 1363–1370 (2019).
Manrai, A. K. et al. Genetic misdiagnoses and the potential for health disparities. N. Engl. J. Med. 375, 655–665 (2016).
Spratt, D. E. et al. Racial/ethnic disparities in genomic sequencing. JAMA Oncol. 2, 1070–1074 (2016).
Hindorff, L. A., Bonham, V. L. & Ohno-Machado, L. Enhancing diversity to reduce health information disparities and build an evidence base for genomic medicine. Pers. Med. 15, 403–412 (2018).
Bentley, A. R., Callier, S. & Rotimi, C. N. Diversity and inclusion in genomic research: why the uneven progress? J. Community Genet. 8, 255–266 (2017).
Knerr, S., Wayman, D. & Bonham, V. L. Inclusion of racial and ethnic minorities in genetic research: advance the spirit by changing the rules? J. Law Med. Ethics 39, 502–512 (2011).
Landry, L. G., Ali, N., Williams, D. R., Rehm, H. L. & Bonham, V. L. Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice. Health Aff. (Millwood) 37, 780–785 (2018).
Hindorff, L. A. et al. Prioritizing diversity in human genomics research. Nat. Rev. Genet. 19, 175–185 (2018).
Popejoy, A. B. et al. The clinical imperative for inclusivity: race, ethnicity, and ancestry (REA) in genomics. Hum. Mutat. 39, 1713–1720 (2018).
Wolf, S. M., Bonham, V. L. & Bruce, M. A. How can law support development of genomics and precision medicine to advance health equity and reduce disparities? Ethn. Dis. 29, 623–628 (2019).
Bustamante, C. D., De La Vega, F. M. & Burchard, E. G. Genomics for the world. Nature. 475, 163–165 (2011).
Denny, J. C. et al. The “All of Us” Research Program. N. Engl. J. Med. 381, 668–676 (2019).
Hoskins, K. F. et al. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center. Cancer. 124, 3733–3741 (2018).
Kaphingst, K. A., Stafford, J. D., McGowan, L. D., Seo, J., Lachance, C. R. & Goodman, M. S. Effects of racial and ethnic group and health literacy on responses to genomic risk information in a medically underserved population. Health Psychol. 34, 101–110 (2015).
Komenaka, I. K. et al. Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety net institution. J. Community Genet. 7, 177–183 (2016).
Rana, H. Q. et al. A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings. J. Community Genet. 9, 233–241 (2018).
Sanderson, S. C. et al. Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study. J. Community Genet. 4, 469–482 (2013).
Kullo, I. J. et al. The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: design and initial results. Mayo Clin. Proc. 93, 1600–1610 (2018).
Shaibi, G. Q. et al. Developing a process for returning medically actionable genomic variants to Latino patients in a Federally Qualified Health Center. Public Health Genomics 21, 77–84 (2018).
Olson, J. E. et al. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin. Proc. 88, 952–962 (2013).
Ye, Z., Kalloo, F. S., Dalenberg, A. K. & Kullo, I. J. An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease. Glob. Cardiol. Sci. Pract. 2013, 82–90 (2013).
Kalia, S. S. et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet. Med. 19, 249–255 (2017).
Shaibi, G. et al. The Sangre Por Salud Biobank: facilitating genetic research in an underrepresented Latino community. Public Health Genomics 19, 229–238 (2016).
Sutton, E. J., Kullo, I. J. & Sharp, R. R. Making pretest genomic counseling optional: lessons from the RAVE study. Genet. Med. 20, 1157–1158 (2018).
O’Connor, A. M. Validation of a decisional conflict scale. Med. Decis. Making 15, 25–30 (1995).
Brehaut, J. C. et al. Validation of a decision regret scale. Med. Decis. Making 23, 281–292 (2003).
O’Connor, A. M. User manual—Decisional Conflict Scale. https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf (2010).
Kaphingst, K. A. et al. Effects of informed consent for individual genome sequencing on relevant knowledge. Clin. Genet. 82, 408–415 (2012).
Chew, L. D. et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J. Gen. Intern. Med. 23, 561–566 (2008).
Pacyna, J. E. et al. Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study. J. Med. Genet. 56, 317–324 (2019).
Fay, M. P. Two-sided exact tests and matching confidence intervals for discrete data. R J 2, 53 (2010).
Jacobson, H. E., Hund, L. & Soto Mas, F. Predictors of English health literacy among U.S. Hispanic immigrants: the importance of language, bilingualism and sociolinguistic environment. Liter. Numer. Stud. 24, 43–64 (2016).
Pérez-Stable, E. J., Sabogal, F., Otero-Sabogal, R., Hiatt, R. A. & McPhee, S. J. Misconceptions about cancer among Latinos and Anglos. JAMA. 268, 3219–3223 (1992).
Zamudio, C. D., Sanchez, G., Altschuler, A. & Grant, R. W. Influence of language and culture in the primary care of Spanish-speaking Latino adults with poorly controlled diabetes: a qualitative study. Ethn. Dis. 27, 379–386 (2017).
Abraído-Lanza, A. E., Viladrich, A., Flórez, K. R., Céspedes, A. Aguirre, A. N. & De La Cruz, A. A. Commentary: fatalismo reconsidered: a cautionary note for health-related research and practice with Latino populations. Ethn. Dis. 17, 153–158 (2007).
Velasco-Mondragon, E., Jimenez, A., Palladino-Davis, A. G., Davis, D. & Escamilla-Cejudo, J. A. Hispanic health in the USA: a scoping review of the literature. Public Health Rev. 37, 31 (2016).
The authors acknowledge the contributions of the late Carmen Radecki Breitkopf to this work. This study was supported by a grant from the US National Institutes of Health (U01 HG006379) and by the Mayo Clinic Center for Individualized Medicine.
The authors declare no competing interests.
This survey study was embedded in two parent genomic sequencing studies, each of which was reviewed and approved by the Mayo Clinic Institutional Review Board (#15–005013 and #16-004342). Written informed consent was obtained for all participants.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Pacyna, J.E., Shaibi, G.Q., Lee, A. et al. Increasing access to individualized medicine: a matched-cohort study examining Latino participant experiences of genomic screening. Genet Med 23, 934–941 (2021). https://doi.org/10.1038/s41436-020-01079-5